Contact this trialFirst, we need to learn more about you.
Alkylating agents
Carboplatin +1 More for Breast Cancer
Recruiting3 awardsPhase 2
Chicago, Illinois
This trial is testing a new combination of drugs to treat metastatic breast cancer. The drugs are carboplatin and pembrolizumab. Pembrolizumab is an immune therapy drug that has the ability to restore the capacity of controlling and killing cancer cells of an important component of your immune system called T-cells.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service